Cite
APA Citation
Karydis, I., Chan, P. Y., Wheater, M., Arriola, E., Szlosarek, P. W., & Ottensmeier, C. H. (2016). clinical activity and safety of Pembrolizumab in Ipilimumab pre-treated patients with uveal melanoma. Oncoimmunology, 5, . http://access.bl.uk/ark:/81055/vdc_100033975757.0x000024